Philip Siberg

Philip is a serial entrepreneur with a background in venture capital and building up life science companies with strong US focus for over 25 years. He is currently CEO of Senzime (a Nasdaq-listed medical device company), Partner at Southbloom Corporate Finance and Chairman of Nasdaq-listed Acarix. Philip has an MSc. in Engineering and Industrial Economics from the Royal Institute of Engineering (KTH) in Stockholm.

Leave a Reply

Your email address will not be published. Required fields are marked *